|
401 |
The neutron veto of the XENONnT experiment: results with demineralized water
Enthalten in The European physical journal / C / Particles and fields Bd. 85, 24.6.2025, Nr. 6, date:6.2025: 1-16
|
|
|
|
402 |
The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
Enthalten in Substance abuse treatment, prevention, and policy Bd. 15, 2.1.2020, Nr. 1, date:12.2020: 1-7
|
|
|
|
403 |
The SCIentinel study - prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS) - study protocol and interim feasibility data
Enthalten in BMC neurology Bd. 13, 9.11.2013, Nr. 1, date:12.2013: 1-12
|
|
|
|
404 |
The XENON1T dark matter experiment
Enthalten in The European physical journal / C / Particles and fields Bd. 77, 18.12.2017, Nr. 12, date:12.2017: 1-23
|
|
|
|
405 |
The XENONnT dark matter experiment
Enthalten in The European physical journal / C / Particles and fields Bd. 84, 7.8.2024, Nr. 8, date:8.2024: 1-29
|
|
|
|
406 |
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study
Enthalten in Leukemia Bd. 38, 27.8.2024, Nr. 11, date:11.2024: 2419-2428
|
|
|
|
407 |
Toll-like Rezeptor-vermittelte Signale in regulatorische T-Zellen fördern ein defektes Immunsystem in Patienten mit Plattenepithelkarzinomen im Kopf-Hals-Bereich
Enthalten in GMS current posters in otorhinolaryngology, head and neck surgery Bd. 6, 22.04.2010
|
|
|
|
408 |
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
Enthalten in European radiology Bd. 33, 12.4.2023, Nr. 9, date:9.2023: 6179-6188
|
|
|
|
409 |
Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo
Enthalten in Clinical and translational oncology Bd. 14, 8.5.2012, Nr. 5, date:5.2012: 376-381
|
|
|
|
410 |
Translational pharmacokinetic and pharmacodynamic modelling of the anti-ADAMTS-5 NANOBODY® (M6495) using the neo-epitope ARGS as a biomarker
Enthalten in Journal of pharmacokinetics and pharmacodynamics Bd. 52, 20.12.2024, Nr. 1, date:2.2025: 1-12
|
|
Administration
